GSK3 beta antibody
Principal name
GSK3 beta antibody
Alternative names for GSK3 beta antibody
GSK-3 beta, Glycogen synthase kinase-3 beta, GSK3B
Ncbi ID
NP_001139628.1, 9606, 10116, NP_114469.1, NP_001139628, NP_002084, NM_002093, NP_062801.1, NM_019827, NM_032080
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Paraffin Sections (P), Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), ELISA (detection) (E(detection)), Frozen Sections (C), Flow Cytometry (F)
Background of GSK3 beta antibody
Glycogen synthase kise 3 (GSK3) is a proline-directed serine/threonine protein kise that was origilly identified for its role in glycogen metabolism; however, subsequently it was shown to serve pleiotropic functions, including embryonic development, gene transcription, and neurol cell function. Mammalian GSK has two isoforms encoded by distinct genes: GSK3A produces a 51-kD GSK3-alpha protein and GSK3B a 47-kD GSK3-beta protein. Phosphorylation of Tyr279/Tyr216 on GSK3alpha/beta is important for enzymatic activity, whereas ictivation of GSK3 can be achieved through phosphorylation of Ser21/Ser9 residues within the N-termil domain on GSK3-alpha/beta, respectively. Upstream kises PKA, AKT/PKB, PKC, p90RSK/MAPKAP and p70S6K are known to phosphorylate Ser9 of GSK3-beta. Furthermore, GSK3 is also regulated via interactions with WNT ligand and its receptor Frizzled/co-receptor LRP5/6, and this interaction releases GSK3 from a multi-protein complex formed by beta-catenin, axin, and adenomatous polyposis coli (APC), which prevents GSK3-mediated beta-catenin degradation and induces beta-catenin-dependent gene transcription. GSK3 is one of the few sigling mediators that play central roles in a diverse range of sigling pathways, including those activated by WNT, hedgehog, growth factors, cytokines, and G protein-coupled ligands. GSK3 dysregulation, particularly hyperactivation, with various pathological conditions, including diabetes mellitus, obesity, inflammation, neurological disorders, and tumorigenesis.
General readings
Castaño Z. et al.The neuron-specific isoform of glycogen synthase kinase-3β is required for axon growth. Journal of Neurochemistry, April 2010, Volume 113, Issue 1, pages 117–130.
Western blot analysis of GSK-3β with mouse small intestine lysate.
Detection of Endogenous GSK3 beta: Whole cell lysates of serum starved tumor cells (20.000 cells per lane) were applied to SDS-PAGE and transferred to PVDF membranes. Immunoblots were probed with mab GSK3-11B9 (0.5 µg/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec). Lane 1: A431Lane 2:SW480 Lane 3: SW620 Lane 4: HT29 Lane 5: MCF7 Lane 6: MDA-MB-231 Lane 7: T47D
Phosphospecificity Whole cell extracts of control (co), EGF stimulated (EGF) or pervanadate treated (VH) A431 tumor cells were applied to SDS-PAGE (ca 20.000 cells per lane) and transferred to PVDF membranes. Immunoblots were probed with mab GSK-3A8 (0.5 µg/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec).
Phosphospecificity Whole cell extracts of control (co) and pervanadate (VH) treated A431 tumor cells were applied to SDS-PAGE (ca 20.000 cells per lane) and transferred to PVDF membranes. Immunoblots were probed with mab GSK3b-2D3 (0.5 µg/ ml) for 1h at RT and developed by ECL (exp. time: 30 sec).
Immunoperoxidase of monoclonal antibody to GSK3B on formalin-fixed paraffin-embedded human tonsil. [antibody concentration 3 ug/ml]
Proximity Ligation Analysis (PLA) of protein-protein interactions between SMAD1 and GSK3B. HeLa cells were stained with anti-SMAD1 rabbit purified polyclonal 1:1200 and anti-GSK3B mouse monoclonal antibody 1:50. Signals were detected by Duolink® 30 Detection Kit 613(red), and nuclei were counterstained with DAPI (blue). Each red dot represents the detection of protein-protein interaction complex.
Detection limit for recombinant GST tagged GSK3B is approximately 3ng/ml as a capture antibody.
GSK3B polyclonal antibody (A01), Lot # 060707JCS1 Western Blot analysis of GSK3B expression in SJCRH30 ( Cat # L027V1 ).
Figure 1. Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using GSK3B antibody (#AP02304PU).
Figure 2. Immunofluorescence staining of methanol-fixed Hela cells showing cytoplsamic staining using GSK3B antibody(#AP02304PU)
Figure 3. Western blot analysis of extracts from 293 cells untreated (Lane 1) or treated with Serum (Lane 2) using GSK3B antibody (#AP02304PU).
Figure 1. Immunohistochemical analysis of Paraffin-embedded human breast carcinoma tissue, using GSK3B pTyr216 antibody AP02535PU (left) or the same antibody preincubated with blocking peptide (right).
Figure 2. Immunofluorescence staining of methanol-fixed HeLa cells using GSK3B pTyr216 antibody AP02535PU (Red).
Figure 3. Western blot analysis of extract from 293 cells untreated or treated with PMA using GSK3B pTyr216 antibody AP02535PU.
Immunohistochemical analysis of paraffin- embedded human breast carcinoma tissue using GSK3β antibody (AP02546PU-S or AP02546PU-N).
Immunofluorescence staining of methanol-fixed HeLa cells showing cytoplasmic and nuclear staining using GSK3 beta antibody
Western Blot analysis of extracts from A2780 and HT29 cells using GSK3beta antibody
Western blot analysis of extracts from 293 cells treated with 10% serum (30min), using GSK3β antibody (AP02546PU-S or AP02546PU-N).
Western blot analysis of extract from 293 cells, untreated or treated with insulin (40µM, 30min), using GSK3β Antibody (Lane 1 and 2) and GSK3β (PTyr216) Antibody (Lane 3 and 4).
Immunohistochemistry (IHC) analyzes of GSK3β antibody (Cat.-No.: AP06391PU-N) in paraffin-embedded human breast carcinoma tissue.
Western blot(WB) analysis of GSK3β antibody (Cat.-No.: AP06391PU-N) in extracts from 293 cells treated with serum 10% 15 or from Jurkat cells treated with Insulin 0.01U/ml 15.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with GSK3B (phospho S21/29) polyclonal antibody ( Cat # PAB0479 ) which was peroxidase-conjugated to the secondary antibody followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. HC = hepatocarcinoma.
The GSK3B (phospho S21/29) polyclonal antibody ( Cat # PAB0479 ) is used in Western blot to detect Phospho-GSK3B-S21/29 in mouse thymus tissue lysate.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with GSK3B polyclonal antibody ( Cat # PAB3336 ) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry ; clinical relevance has not been evaluated. HC = hepatocarcinoma.
The GSK3B polyclonal antibody ( Cat # PAB3336 ) is used in Western blot to detect GSK3B in 293 cell lysate.
Western blot analysis of extract from 293 cells , untreated with insulin ( 40 µM , 30 min ) , using GSK3B polyclonal antibody ( Cat # PAB5379 ) .
Western blot analysis of HeLa cell lysate ( each 30 µg ) were resolved by SDS - PAGE , transferred to PVDF membrane and probed with GSK3B monoclonal antibody , clone 1F7 ( 1 : 2000 ) ( Cat # MAB1087 ) . Proteins were visualized using a goat anti - mouse secondary antibody conjugated to HRP and an ECL detection system.
Immunohistochemistry (IHC) analysis of GSK3b pSer9 antibody (Cat.-No.: AP01596PU-N) in paraffin-embedded human breast carcinoma tissue.
Western blot (WB) analysis of GSK3β pSer9 antibody (Cat.-No.: AP01596PU-N) in extracts from HeLa cells treated with EGF.
Cell lysates of HeLa(30ug) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human GSK3beta (1:2000). Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system.
Western blot analysis: Cell lysates of HeLa (each 30 ug) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human GSK3β (1:2000). Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.
The anti-Phospho-GSK3B-S21/29 Pab (Cat. #AP12618PU-N) is used in Western blot to detect Phospho-GSK3B-S21/29 in mouse thymus tissue lysate.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining.
The anti-GSK3B Pab is used in Western blot to detect GSK3B in 293 cell lysate.
Western blot analysis of rabbit spleen fibroblasts serum starved for 2 hrs (lane 1) or treated with pervanadate (1 mM) for 30 minutes (lane 2). The blot was probed with GSK3B monoclonal antibody, clone M131 ( Cat # MAB1372 ).
Western blot analysis of rabbit spleen fibroblasts serum starved for 2 hrs (lane 1) or treated with pervanadate (1 mM) for 30 minutes (lane 2). The blot was probed with GSK3B (phospho Y216) monoclonal antibody, clone M132 ( Cat # MAB1373 ).
Proximity Ligation Analysis (PLA) of protein-protein interactions between GSK3B and CTNNB1. HeLa cells were stained with anti-GSK3B rabbit purified polyclonal 1:1200 and anti-CTNNB1 mouse monoclonal antibody 1:50. Signals were detected by Duolink® 30 Detection Kit 613(red), and nuclei were counterstained with DAPI (blue). Each red dot represents the detection of protein-protein interaction complex.
GSK3B MaxPab rabbit polyclonal antibody. Western Blot analysis of GSK3B expression in mouse stomach.
Western Blot analysis of GSK3B expression in transfected 293T cell line (H00002932-T05) by GSK3B MaxPab polyclonal antibody.Lane 1: GSK3B transfected lysate(48.00 KDa).Lane 2: Non-transfected lysate.
Immunohistochemistry of GSK3B (phospho S9) polyclonal antibody ( Cat # PAB10055 ) was used at a 1 : 200 dilution to detect GSK3B by immunohistochemistry in human ovarian cancer tumor tissue.Tissue was formalin-fixed and paraffin embedded.Personal Communication, Alan Yen, Life Span Biosciences, Seattle, WA.
Western blot analysis of GSK3B in A-431 whole cell lysates using GSK3B polyclonal antibody ( Cat # PAB12421 ).
The NIH/3T3 cell lysates derived from conditioned culture medium ( lane 1 ) or without treatment ( lane 2 ) were resolved onto 10% SDS-PAGE, transferred onto NC membrane, and followed by an immunoblotting with GSK3B ( phospho Y216 ) polyclonal antibody ( Cat # PAB12624 ) ( lane 1 ) at 1 : 500.
The NIH/3T3 cell lysate derived from conditioned culture medium was resolved onto 10% SDS-PAGE, transferred onto NC membrane, and followed by an immunoblotting with GSK3B ( phospho S9 ) polyclonal antibody ( Cat # PAB12625 ) at 1 : 500.
The mouse muscle tissue lysates were resolved onto 10% SDS-PAGE, transferred to NC membrane, and followed by an immunoblotting with GSK3B polyclonal antibody ( Cat # PAB12688, lane 1 ) at 1 : 500, or with a pre-incubation of immunizing peptide ( lane 2 ).
The mouse muscle tissue lysates were resolved onto 10% SDS-PAGE, transferred to NC membrane, and followed by an immunoblotting with GSK3B polyclonal antibody ( Cat # PAB12689, lane 1 ) at 1 : 500, or with a pre-incubation of immunizing peptide ( lane 2 ).
The NIH/3T3 cell lysate derived was resolved onto 10% SDS-PAGE, transferred onto NC membrane, and followed by an immunoblotting with GSK3B polyclonal antibody ( Cat # PAB12690 ) at 1 : 500.
Western blot analysis of GSK3B with mouse small intestine lysate.
Western blot of rat cortex lysate showing specific immunolabeling of the ~46k Gsk3b protein phosphorylated at Ser9 (control, lane 1). Immunolabeling is blocked by the phospho-peptide (Peptide, lane 2) used as antigen but not by the corresponding dephosphopeptide (not shown).
Figure 1. Western blot of rat cortex lysate showing specific immunolabeling of the ~46k GSK3B protein phosphorylated at Ser9 (control). Immunolabeling is blocked by the phospho-peptide (peptide) used as antigen but not by the corresponding dephosphopeptide (not shown).
Immunoblot analysis of cell lysates.Lane 1 : HeLa cell lysate. Lnae 2 : A-431 cell lysate.Lane 3 : Jurkat cell lysate.Lane 4 : L929 cell lysate.Lane 5 : PC-12 cell lysate.
Human brain; Brain, cortex; GSK3B antibody - C-terminal region (ARP54644_P050) in Human brain cells using Immunohistochemistry
Human Hela; Host:Rabbit. Target Name:GSK3B. Sample Tissue:Hela. Antibody Dilution: 1.0ug/ml. GSK3B is supported by BioGPS gene expression data to be expressed in HeLa.; GSK3B antibody - C-terminal region (ARP54644_P050) in Human Hela cells using Western Blot
Human 721_B; WB Suggested Anti-GSK3B Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: 721_B cell lysate. GSK3B is supported by BioGPS gene expression data to be expressed in 721_B.; GSK3B antibody - C-terminal region (ARP54644_P050) in Human 721_B cells using Western Blot
Hum. Fetal Heart; Host:Rabbit. Target Name:GSK3B. Sample Tissue:Human Fetal Heart. Antibody Dilution: 1.0ug/ml.; GSK3B antibody - C-terminal region (ARP54644_P050) in Hum. Fetal Heart cells using Western Blot
Human Kidney (formalin-fixed, paraffin-embedded) stained with GSK3B antibody AP22680PU-N at 20 µg/ml followed by biotinylated goat anti-rabbit IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen.
Human Placenta (formalin-fixed, paraffin-embedded) stained with GSK3B antibody AP22680PU-N at 20 µg/ml followed by biotinylated goat anti-rabbit IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen.
Lane 1: MW markerLane 2: HeLaLane 3: JurkatLane 4: 3T3Lane 5: PC-12Lane 6: MDBK
Skeletal muscle, Human: Formalin-Fixed, Paraffin-Embedded (FFPE)
Pancreas, Human: Formalin-Fixed, Paraffin-Embedded (FFPE)
Immunohistochemical analysis of GSK3 beta (pS9) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Western blot analysis of GSK3 beta (pS9) expression in MCF7 (A); NIH3T3 (B); PC12 (C) whole cell lysates.
Western blot analysis of GSK3 beta (pS9) expression in HEK293T UV-treated (A); rat kidney (B) whole cell lysates.
Immunohistochemical analysis of GSK3 beta (pS9) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugad compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Western blot analysis of extracts from 293 cells treated with serum, using GSK3ß (Ab-9) Antibody antibody.The lane on the right is treated with the synthesized peptide.
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using GSK3ß (Ab-9) Antibody antibody.The picture on the right is treated with the synthesized peptide.
Anti-GSK3B / GSK3 Beta antibody IHC of human ovary. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.
WB using Rabbit-anti-GSK3B pS9 antibody at a 1:1,000 dilution. All lanes contain human 293T whole cell lysate showing a band at 47 kDa. Cells were serum starved for 24 h prior to extraction. Key: Lane 1 Control, Lane 2 treated with IGF-1 (100 ng/ml) for 20', lane 3 pre-treated with 10 uM LY294002 (selective PI3K inhibitor) and treated with IGF-1 (100 ng/ml) for 20'. Molecular weight markers confirm a MW of ~ 49 kDa. Use a 1:2,000 dilution of HRP Goat-a-Rabbit IgG for detection.
Rabbit anti-GSK3B pS9 was used at a 1:200 dilution to detect GSK3B by immunohistochemistry in human ovarian cancer tumor tissue. Tissue was formalin-fixed and paraffin embedded. Personal Communication, Alan Yen, LifeSpanBiosciences, Seattle, WA.
Western blot analysis of Human small intestine stromal cancer tissue using TA323060 (GSK3B Antibody) at dilution 1/100
Mouse Gsk3b Antibody (N-term) (Cat. #TA324570) western blot analysis in mouse NIH-3T3 cell line lysates (35ug/lane).This demonstrates the Gsk3b antibody detected the Gsk3b protein (arrow).
Mouse Gsk3b Antibody (N-term) (TA324570)immunohistochemistry analysis in formalin fixed and paraffin embedded mouse brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of Mouse Gsk3b Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Western blot analysis of GSK3 beta expression in HeLa whole cell lysates,The lane on the left is treated with the antigen-specific peptide.
Western blot analysis of GSK-3Beta in a cell line mix, using a 1:1000 dilution of the antibody
Hela cell extract was resolved by electrophoresis, transferred to nitrocellulose and probed with rabbit anti-GSK 3ß antibody. Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system.
Recombinant human full length GSK3 beat containing an N-terminal GST tag protein (400 ng per lane) was resolved by electrophoresis, transferred to nitrocellulose and probed with rabbit anti-GSK 3ß antibody. Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system.
Western Blot: GSK3 beta Antibody [TA336702] - Detection of GSK3B in A431 whole cell lysates using TA336702.
Immunocytochemistry/Immunofluorescence: GSK3 beta Antibody [TA336702] - GSK3 beta antibody was tested in Hela cells with DyLight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).
Western Blot: GSK3 beta Antibody (3D10) [TA336772] - Western blot analysis using GSK3 beta mouse mAb against A549 (1), K562 (2), PC-12 (3), NIH/3T3 (4), and HEK293 (5) cell lysates.
Immunohistochemistry-Paraffin: GSK3 beta Antibody (3D10) [TA336772] - Immunohistochemical analysis of paraffin-embedded human lung cancer (left) and breast cancer tissues (right) using GSK3 beta mouse mAb with DAB staining.
Immunocytochemistry/Immunofluorescence: GSK3 beta Antibody (3D10) [TA336772] - Analysis of NIH/3T3 (left) and U251 (right) cells using GSK3 beta mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-55
Flow Cytometry: GSK3 beta Antibody (3D10) [TA336772] - Flow cytometric analysis of Hela cells using GSK3 beta mouse mAb (green) and negative control (purple).
Western blot analysis of GSK3 beta expression in mouse brain (A); mouse heart (B); rat brain (C); rat heart (D) whole cell lysates.
Immunohistochemical analysis of GSK3 beta staining in mouse lung formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Human Brain stained with anti-GSK-3 antibody.
Western blot analysis of GSK3 beta phosphorylation expression in EGF treated HeLa whole cell lysates,The lane on the left is treated with the antigen-specific peptide.
The anti-Phospho-GSK3B-S21/29 Pab (Cat. #TA324769) is used in Western blot to detect Phospho-GSK3B-S21/29 in mouse thymus tissue lysate.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.
Predicted band size: 46 kDa . Positive control: 293 cells treated with PMA lysate. Recommended dilution: 1/ 500-1000. (Gel: 10%SDS-PAGE Lane1: untreated 293 cells lysate Lane2: 293 cells treated with PMA lysate Lysates: 30 ug per lane Primary antibody: 1/500 dilution Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution Exposure time: 1 minute)
Predicted cell location: Cytoplasm, Nucleus, Cell membrane. Positive control: Human breast carcinoma tissue. Recommended dilution: 1/ 50-100 The image on the left is immunohistochemistry of paraffin-embedded Human breast carcinoma tissue using GSK3B (Phospho-Tyr216) antibody at dilution 1/50, on the right is treated with the synthetic peptide. (Original magnification:x200)
Predicted cell location: Cytoplasm, Nucleus, Cell membrane. Positive control: Hela cells. Recommended dilution: 1/ 100-200.The image is immunofluorescence of methanol-fixed Hela cells using GSK3B (Phospho-Tyr216) antibody at dilution 1/100. (Original magnification:×200)
Western blot analysis of extracts from COLO, using GSK3ß (Phospho-Ser9) AntibodyThe lane on the right is treated with the synthesized peptide.
Western blot of rat cortex lysate showing specific immunolabeling of the ~46k GSK3β protein phosphorylated at Ser9 (control). Immunolabeling is blocked by the phospho-peptide (peptide) used as antigen but not by the corresponding dephosphopeptide (not shown).
- Quick-Filters:
- Highly Validated (3)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP02546PU-N | GSK3 beta antibody |
||||||
 |
Rabbit | Aff - Purified | Hu, Ms | ICC/IF, P, WB |
0.1 mg /
€300.00
|
||
| OriGene Technologies GmbH | |||||||
 +3 additional images |
Highly validated antibody! |
||||||
| AP02546PU-S | GSK3 beta antibody |
||||||
|
Rabbit | Aff - Purified | Hu, Ms | ICC/IF, P, WB |
50 µg /
€230.00
|
||
| OriGene Technologies GmbH | |||||||
| +3 additional images |
Highly validated antibody! |
||||||
| AP22887PU-N | GSK3 beta antibody |
||||||
 |
Rabbit | Purified | Bov, Hu, Ms, Rt | ICC/IF, P, WB |
50 µg /
€425.00
|
||
| OriGene Technologies GmbH | |||||||
| +3 additional images |
Highly validated antibody! |
||||||
| TA309159 | GSK3 beta antibody |
||||||
| Rabbit Anti-Glycogen synthase kinase 3 B (GSK3B) (Ser9) Antibody (Phospho-Specific) | |||||||
 |
Rabbit | IgG | Purified | Rt | WB |
0.1 ml /
€405.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA313125 | GSK3 beta antibody |
||||||
| Rabbit polyclonal GSK3beta (Ab-9) antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA313126 | GSK3 beta antibody |
||||||
| Rabbit polyclonal GSK3beta (Ser9) antibody(Phospho-specific) | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA317698 | GSK3 beta (4-12) pSer9 antibody |
||||||
| GSK3B / GSK3 Beta Rabbit Polyclonal (pSer9) Antibody | |||||||
 |
Rabbit | Aff - Purified | Hu | E, ICC/IF, IP, P, WB |
50 µg /
€425.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA319263 | GSK3 beta pSer9 antibody |
||||||
| Rabbit polyclonal GSK3 Beta phospho S9 antibody | |||||||
 |
Rabbit | Aff - Purified | Hu | E, IP, P, WB |
0.1 mg /
€515.00
|
||
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA323060 | GSK3 beta antibody |
||||||
| Anti-GSK3B Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA323991 | GSK3 beta antibody |
||||||
| Anti-GSK3B (Phospho-Tyr216) Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | ICC/IF, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|||||||
| TA324570 | GSK3 beta antibody |
||||||
| Rabbit polyclonal Mouse Gsk3b Antibody (N-term) | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA324769 | GSK3 beta antibody |
||||||
| Rabbit polyclonal Bi-Phospho-GSK3B(S21/29) Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA326007 | GSK3 beta antibody |
||||||
| Rabbit Polyclonal GSK3 beta Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA326008 | GSK3 beta antibody |
||||||
| Rabbit Polyclonal GSK3 beta (Ser9) Antibody (Phospho-specific) | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA326426 | GSK3 beta antibody |
||||||
| Rabbit polyclonal GSK-3Beta Antibody | |||||||
 |
Rabbit | Purified | Bov, Hu, Ms, Rt | WB |
0.1 mg /
€355.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA327940 | GSK3 beta antibody |
||||||
| Rabbit Polyclonal anti-GSK-3ß Antibody | |||||||
 |
Rabbit | IgG | Poly6042 | Purified | Hu, Ms | WB |
0.2 ml /
€255.00
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| TA333208 | GSK3 beta antibody |
||||||
| Phospho-GSK3B-S9 Rabbit Polyclonal Antibody | |||||||
|
Rabbit | IgG | Purified | Hu, Ms, Rt |
0.1 mg /
€335.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA336772 | GSK3 beta antibody |
||||||
| Mouse Monoclonal GSK-3 beta Antibody (3D10) | |||||||
![Western Blot: GSK3 beta Antibody (3D10) [TA336772] - Western blot analysis using GSK3 beta mouse mAb against A549 (1), K562 (2), PC-12 (3), NIH/3T3 (4), and HEK293 (5) cell lysates.](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/OriGene/NBP1-47470-1-W.jpg) |
Mouse | IgG2a | 3D10 | Purified | Hu, Ms, Prim, Rt | C, E, F, ICC/IF, P, WB |
0.1 ml /
€415.00
|
| OriGene Technologies, Inc. | |||||||
| +3 additional images |
|||||||
| AM08186PU-N | GSK3 beta antibody |
||||||
|
Mouse | IgG2a | SBGSK3a4 | Purified | Hu, Ms, Rt | E, IP, WB |
0.1 mg /
€460.00
|
| OriGene Technologies GmbH | |||||||
| AM08186SE-N | GSK3 beta antibody |
||||||
|
Mouse | IgG2a | SBGSK3a4 | Sepharose | Hu, Ms, Rt | E, IP, WB |
50 Tests /
€600.00
|
| OriGene Technologies GmbH | |||||||